Potential Impact of Revising the Diagnostic Criteria for Gestational Diabetes on Maternal Pregnancy and Infant Perinatal Outcomes
Journal of Diabetes · 2026-05 · 18 (5)
DOI: 10.1111/1753-0407.70232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 12.05.2026. Verfasst von Qiliang Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Liggins Institute, University of Auckland, New Zealand, Auckland, New Zealand. Hauptthemen laut MEDLINE: Diabetes, Gestational, Pregnancy Outcome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
The revised diagnostic criteria for gestational diabetes (GDM) in New Zealand include lowering the fasting glucose from the current ≥ 5.5 to ≥ 5.3 mmol/L and replacing the current 2‐h post‐load glucose (≥ 9.0 mmol/L) with a 1‐h glucose (≥ 10.6 mmol/L). We assessed the effects of these changes on the demographics of those diagnosed and their perinatal outcomes. Materials and Methods Participants in the GEMS trial were grouped as meeting only the revised criteria (Additional group), only the current criteria (Missed group), both criteria (Both‐Criteria group), and neither criteria (Non‐GDM group).
Results
GDM prevalence among 3921 participants was 6.8% using the revised criteria and 5.8% using the current criteria (risk ratio 1.18, 95% CI 1.00–1.40). Women in the Additional ( n = 125) and Missed groups ( n = 83), who would be affected by the changes, were more likely to be overweight/obese, have a family history of diabetes, and have Asian ethnicity than women in the Non‐GDM group ( n = 3562). They also had less gestational weight gain and more induced labors, while their infants were born earlier, had lower birthweight, and more neonatal hypoglycemia (all p < 0.001). Women in the Missed group had lower BMI and fewer were of Pacific ethnicity than the Both‐Criteria group ( n = 151). They also had less pharmacotherapy use and postpartum hemorrhage.
Conclusions
Using the revised criteria will increase GDM diagnoses by identifying a high‐risk group of women likely to benefit from treatment, but 35.5% of women currently treated for GDM will no longer be diagnosed, potentially compromising their health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liggins Institute, University of Auckland, New Zealand, Auckland, New Zealand.
- Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand, Auckland, New Zealand.
ORCID-Profile: Qiliang Liu, Jane E Harding, Greg D Gamble, Lisa Dawes, Caroline A Crowther
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Liu, Q., Harding, J. E., Gamble, G. D., Eagleton, C., Dawes, L., & Crowther, C. A. (2026). Potential Impact of Revising the Diagnostic Criteria for Gestational Diabetes on Maternal Pregnancy and Infant Perinatal Outcomes. Journal of Diabetes, 18(5). https://doi.org/10.1111/1753-0407.70232
Vancouver
Liu Q, Harding JE, Gamble GD, Eagleton C, Dawes L, Crowther CA. Potential Impact of Revising the Diagnostic Criteria for Gestational Diabetes on Maternal Pregnancy and Infant Perinatal Outcomes. Journal of Diabetes. 2026;18(5). doi:10.1111/1753-0407.70232
BibTeX
@article{Liu2026,
author = {Liu, Qiliang and Harding, Jane E and Gamble, Greg D and Eagleton, Carl and Dawes, Lisa and Crowther, Caroline A},
title = {Potential Impact of Revising the Diagnostic Criteria for Gestational Diabetes on Maternal Pregnancy and Infant Perinatal Outcomes},
journal = {Journal of Diabetes},
year = {2026},
volume = {18},
number = {5},
doi = {10.1111/1753-0407.70232}
}
EUVIMED